Use of Diabetes-Specific Protein Supplement Improves Glycemic Control in Type 2 Diabetes: Study

India: Researchers have discovered in a new study that using a diabetes-specific protein supplement as a partial breakfast replacement improves blood glucose control in people with type 2 diabetes mellitus…

Continue ReadingUse of Diabetes-Specific Protein Supplement Improves Glycemic Control in Type 2 Diabetes: Study

Unexpected Hair Loss Reported After Single-Dose Intravesical Gemcitabine in Bladder Cancer Patients: Case Series

USA: Researchers have drawn attention to an unusual but potentially distressing adverse effect linked to a commonly used postoperative treatment for non–muscle-invasive bladder cancer (NMIBC).          A…

Continue ReadingUnexpected Hair Loss Reported After Single-Dose Intravesical Gemcitabine in Bladder Cancer Patients: Case Series

Once-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial

Pfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no weight-loss plateau, in adults with obesity or overweight without type…

Continue ReadingOnce-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial

USFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection

New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…

Continue ReadingUSFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection

OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout

New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic (semaglutide), marking a significant milestone for the company's expansion in…

Continue ReadingOneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout